Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
22.24
+0.24 (1.09%)
At close: Mar 9, 2026, 4:00 PM EDT
23.00
+0.76 (3.42%)
After-hours: Mar 9, 2026, 4:24 PM EDT
Pacira BioSciences Employees
As of December 31, 2025, Pacira BioSciences had 829 total employees, including 825 full-time and 4 part-time employees. The number of employees increased by 39 or 4.94% compared to the previous year.
Employees
829
Change (1Y)
39
Growth (1Y)
4.94%
Revenue / Employee
$876,250
Profits / Employee
$8,485
Market Cap
900.50M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 829 | 39 | 4.94% | 825 | 4 |
| Dec 31, 2024 | 790 | 78 | 10.96% | 788 | 2 |
| Dec 31, 2023 | 712 | -3 | -0.42% | 711 | 1 |
| Dec 31, 2022 | 715 | 18 | 2.58% | 715 | 0 |
| Dec 31, 2021 | 697 | 73 | 11.70% | 697 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Perrigo Company | 8,379 |
| Evotec SE | 4,788 |
| Tilray Brands | 2,842 |
| Amphastar Pharmaceuticals | 1,976 |
| Alvotech | 1,012 |
| Cronos Group | 610 |
| Collegium Pharmaceutical | 423 |
| Harrow | 373 |
PCRX News
- 3 days ago - Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 days ago - Pacira BioSciences to Participate in Fireside Chat at the Barclays 28th Annual Global Healthcare Conference - GlobeNewsWire
- 10 days ago - Pacira BioSciences, Inc. (PCRX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Pacira BioSciences Reports Fourth Quarter and Full-Year 2025 Financial Results - GlobeNewsWire
- 25 days ago - Pacira to Report 2025 Financial Results on Thursday February 26, 2026 - GlobeNewsWire
- 25 days ago - Pacira Highlights New NOPAIN Act Survey Data Conducted by Voices for Non-Opioid Choices - GlobeNewsWire
- 4 weeks ago - Pacira BioSciences: Mispriced On Generic Risks That Are Years Away - Seeking Alpha
- 5 weeks ago - Pacira BioSciences Appoints Samit Hirawat, M.D., to Board of Directors - GlobeNewsWire